학술논문

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 13 May 2023, 401(10388):1571-1583)
Subject
Language
English
ISSN
1474547X
01406736